Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

Recent Press Coverage

  1. Dr. Bilal Mateen, PATH’s Chief AI Officer, highlights GenAI’s potential in diagnostics, disease surveillance, and health communication while addressing challenges like data privacy and equity.
    Published: December 2024
  2. Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024
  3. Nikolaj Gilbert, President and CEO of PATH, shares insights on the growing trend of global health organizations appointing Chief AI Officers (CAIOs) to harness the transformative potential of artificial intelligence in healthcare.
    Published: September 2024
  4. The first vaccine for malaria received major regulatory approval in 2015. It didn’t become part of vaccination programs in Africa until 2024. PATH's Ashley Birkett speaks about the manufacturing plans that GSK had put in place were derailed.
    Published: July 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

996 Item s
996 Item s
    Date
    From
    To
  1. Elie Alam, Keith Ashton, and Bart Cornelissen have joined PATH’s Board of Directors.
    Published: November 2026
    Press Release
  2. During the Union World Conference on Lung Health 2026, PATH will highlight our work advancing innovations for integrated, people-centered tuberculosis care.
    Published: November 2026
    Announcement
  3. With support from the GHIT Fund, the partners will develop a tool to enable early NiV and HeV outbreak detection in rural and low-resource settings, reducing transmission and saving lives.
    Published: October 2026
    Press Release
  4. GHIT Fundの支援のもと、医療資源の限られた地域においてニパウイルス(NiV)およびヘンドラウイルス(HeV)の流行を早期に検出できるツールを開発し、感染拡大の抑制と人命の保護を目指します
    Published: October 2026
    Press Release
  5. PATH’s Sustaining Vaccine Manufacturing program supported Bio Farma in reaching this crucial milestone, which can expand rotavirus protection for young children across Indonesia.
    Published: October 2026
    Announcement